Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical Resection

NCT06161909 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma Thoracic Stage II
Esophageal Squamous Cell Carcinoma Thoracic Stage III
Esophageal Squamous Cell Carcinoma Thoracic Stage IV

Interventions

DRUG: sintilimab

Sponsor

Fujian Medical University Union Hospital